Experimental Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Quarterly Journal of Experimental Physiology 67.3 pp 437-448
© The Physiological Society 1982
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ali, B. H.
Right arrow Articles by Bartlet, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ali, B. H.
Right arrow Articles by Bartlet, A. L.

ANOREXIA AND ANTAGONISM OF THIAMIN UTILIZATION IN POULTRY TREATED WITH FURAZOLIDONE

B. H. Ali 1 and A. L. Bartlet 2

1 Faculty of Veterinary Science, University of Khartoum, P.O. Box 32, Khartoum North, Sudan
2 Department of Veterinary Pharmacology, University of Edinburgh, EH9 1QH

Furazolidone (0·04% w/w in the feed, 10 days) reduced the feed intake and growth in 9 week old chickens, and increased the amount of 5-hydroxytryptamine (5-HT) in the brain. The drug also increased the stimulation of transketolase activity by thiamin pyrophosphate (TPP) in lysed blood cells (TPP effect), and the concentrations of pyruvate and lactate in the blood. Experiments with pair-fed birds showed that the reduction in feed intake in furazolidone-treated chickens could account for the reduced growth. The drug also produced anorexia in ducklings and turkey poults. In chickens, the anorectic action of furazolidone was unaffected by methergoline (1 mg/kg, twice daily, I.M.), and in ducklings furazolidone did not consistently produce anorexia, although it always inhibited monoamine oxidase (MAO) activity in the brain. These observations suggest that the anorectic action of the drug was not tryptaminergic in nature. The increase in the TPP effect found in preparations from furazolidone-treated chickens was absent in preparations from pair-fed birds on unmedicated feed. Thus the TPP effect could be used as an indicator of the effect of the drug on the thiamin status of chickens. However, the increase in the concentrations of pyruvate and lactate in blood was found both in furazolidone-treated birds and pair-fed birds on unmedicated feed, showing that they were attributable to the reduction in feed intake. The TPP effect in furazolidone-treated chickens, 14·49 ± 2·33% (n = 10), was sufficient to suggest a mild deficiency of thiamin pyrophosphate. Thiamin, given at a dosage above the requirement of the vitamin for chickens, did not reduce the anorexia or the TPP effect in furazolidone-treated birds, although it stimulated the feed intake and growth of birds on unmedicated feed. It is proposed that furazolidone antagonized the utilization of thiamin, perhaps by inhibiting its phosphorylation. Following the withdrawal of furazolidone, the TPP effect returned to the control value and the rate of growth of the birds increased and matched that of the controls. Thus the effect of the drug was reversible. Addition of furazolidone to the feed at a concentration of 0·01% w/w for 28 days did not produce anorexia in chickens or affect the amount of 5-HT in the brain. Thus at this level, it is unlikely that the drug would produce adverse effects in poultry.

Submitted on October 9, 1981







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the The Physiological Society.